发明名称 PHASE TRANSFER CATALYZED GLYCOSIDATION OF AN INDOLOCARBAZOLE
摘要 1. A process for the preparation of a compound of Formula I, wherein Q is O, N-R, S, or CH2; X<1> and X<2> are independently selected from: 1) H, 2) halogen, 3) OH, 4) CN, 5) NC, 6) CF3, 7) (C=O)NO2, 8) (C=O)C1-C6 alkyl, 9) (C=O)OC1-C6 alkyl, 10) OCH2OCH2CH2Si(CH3)3, 11) NO2, 12) 9-fluorenylmethylcarbonyl, 13) NR<5>R<6>, 14) OC1-C6alkyl, 15) C1-C6alkyl, 16) C1-C6alkylenearyl, and 17) OC1-C6alkylenearyl; R and R<1> are independently: 1) H, 2) (C=O)C1-C6alkyl, 3) (C=O)CF3, 4) (C=O)OC1-C6 alkyl, 5) 9-fluorenylmethylcarbonyl, 6) a furanose group, or 7) a pyranose group, so long as one of R and R<1> is a furanose group or a pyranose group; R<2> and R<3> are independently OH or H, or R<2> and R<3> are taken together to form an oxo group; R<4> is: 1) H, 2) C1-C10 alkyl, 3) CHO, 4) (C=O)C1-C10alkyl, 5) (C=O)OC1-C10alkyl, 6) C0-C10 alkylenearyl, or 7) C0-C10 alkylene-NR<5>R<6>; R<5> and R<6> are independently: 1) H, 2) (C1-C8alkyl)-(R<7>)2, 3) (C=O)O(C1-C8alkyl), 4) 9-fluorenylmethylcarbonyl, 5) OCH2OCH2CH2Si(CH3)3, 6) (C=O)(C1-C8 alkyl), 7) (C=O)CF3, or 8) (C2-C8 alkenyl)-(R<7>)2, or R<5> and R<6> are taken together with the nitrogen to which they are attached to form N-phthalimido; R<7> is: 1) H, 2) OH, 3) OC1-C6 alkyl, or 4) aryl, said aryl optionally substituted with up to two groups selected from OH, O(C1-C6alkyl), and (C1-C3alkylene)-OH; which comprises the steps of: (a) reacting a furanose or a pyranose with an activating reagent to produce an activated sugar; and (b) coupling the activated sugar with a compound of Formula IV IV wherein R<1A> is H, if Q is O, S, CH2, or N-R and R is not H, otherwise R<1A> is selected from R<1>; in the presence of an aqueous solution of alkali hydroxide and a phase transfer catalyst in a biphasic system to produce the compound of Formula I. 2. The process of Claim 1, wherein R and R<1> are independently selected from a furanose group of Formula IIA or a pyranose group of Formula IIB, when R or R<1> is defined as a furanose group or a pyranose group, respectively: R<8> is independently selected from: 1) hydrogen, 2) C1-C6 alkyl, 3) OH, 4) halogen, 5) O(C1-C6 alkyl), 6) O(C1-C6 alkylene)-aryl, 7) OSO2 (C1-C6 alkyl), 8) OSO2 aryl, 9) OCH2OCH2CH2Si(CH3)3, 10) O(C=O) (C1-C6 alkyl), 11) O (C=O) CF3, 12) azido, or 13) NR<5>R<6>, or two R<8>'s on the same carbon are taken together to be oxo, =N-R<5>, or =N-R<7>; and the furanose or pyranose in Step (a) is a furanose of Formula IIIA or a pyranose of Formula IIIB, respectively: 3. The process according to Claim 2 wherein the activating reagent in Step (a) is selected from an acid halide and the biphasic system in Step (b) is comprised of an organic solvent selected from a hydrocarbon, a nitrile, an ether, a halogenated hydrocarbon, a ketone, or an apolar aprotic solvent. 4. The process according to Claim 3 wherein the activating reagent is selected from SOCl2 or oxalyl chloride. 5. The process according to Claim 3 wherein the biphasic system is comprised of methyl-t-butyl ether, dichloromethane, or trifluorotoluene. 6. The process according to Claim 3 wherein the phase transfer catalyst in Step (b) is (R<A>)44M<+>A<->; R<A> is independently H or C1-C18 aliphatic hydrocarbon; M is N or P; and A is OH, F, Br, Cl, I, HSO4, CN, MeSO3, or PhCH2CO2. 7. The process according to Claim 6, wherein the phase transfer catalyst is tricaprylmethyl ammonium chloride. 8. The process according to Claim 3, wherein the aqueous solution of alkali hydroxide in Step (b) has a concentration of about 5% to about 95% w/w and the alkali hydroxide is selected from lithium hydroxide, sodium hydroxide, potassium hydroxide, and cesium hydroxide. 9. The process of Claim 8 wherein the aqueous solution of alkali hydroxide has a concentration of about 45% to about 50% w/v and the alkali hydroxide is potassium hydroxide or sodium hydroxide. 10. A process for the preparation of a compound of Formula V, wherein R<4> is: 1) H, 2) C1-C10 alkyl, 3) CHO, 4) (C=O)C1-C10alkyl, 5) (C=O)OC1-C10alkyl, 6) C0-C10alkylenearyl, or 7) C0-C10alkylene-NR<5>R<6>; R<5> and R<6> are independently: 1) H, 2) (C1-C8alkyl)-(R<7>)2, 3) (C=O)O(C1-C8alkyl), 4) 9-fluorenylmethylcarbonyl, 5) OCH2OCH2CH2Si(CH3)3, 6) (C=O)(C1-C8alkyl), 7) (C=O)CF3, or 8) (C2-C8 alkenyl)-(R<7>)2, or R<5> and R<6> are taken together with the nitrogen to which they are attached to form N-phthalimido; R<7> is: 1) H, 2) OH, 3) OC1-C6alkyl, or 4) aryl, said aryl optionally substituted with up to two groups selected from OH, O(C1-C6alkyl), and (C1-C3alkylene)-OH; R<9> is: 1) H, 2) C1-C6alkyl, 3) (C1-C6alkylene)-aryl, 4) SO2(C1-C6alkyl), 5) SO2aryl, 6) CH2OCH2CH2Si(CH3)3, 7) (C=O)(C1-C6alkyl), or 8) (C=O)CF3; which comprises the steps of: (a) reacting a sugar derivative of Formula VI with an acid chloride to produce the activated sugar; and (b) coupling the activated sugar with a compound of Formula VII in the presence of an aqueous solution of an alkali hydroxide and tricaprylmethyl ammonium chloride in t-butyl methyl ether to produce the compound of Formula V. 11. A process for the preparation of a compound of Formula VIII, which comprises the steps of: (a) reacting a sugar derivative of Formula IX with thionyl chloride to produce the activated sugar; (b) coupling the activated sugar with a compound of Formula X in the presence of an aqueous solution of potassium hydroxide or sodium hydroxide and tricaprylmethyl ammonium chloride in t-butyl methyl ether to form the glycosidated compound XI; (c) deprotecting the glycosidated product XI by reacting it with catalytic palladium in the presence of hydrogen gas to form the deprotected glycosidated product XII; (d) reacting the deprotected glycosidated product XII with an aqueous solution of alkali hydroxide to form anhydride XIII; and (e) reacting anhydride XIII with 2-hydrazino-1, 3-propanediol to produce the compound of Formula VIII. 12. The process of Claim 10 wherein Step (A) is conducted in tert-butyl-methyl ether or tetrahydrofuran at a temperature of about -10 degree C to about 30 degree C and Step (B) is conducted at a temperature of about 0 degree C to about 40 degree C. 13. The process of Claim 12, wherein the potassium hydroxide or sodium hydroxide in step (b) is added before the tricaprylmethyl ammonium chloride.
申请公布号 EA005209(B1) 申请公布日期 2004.12.30
申请号 EA20030000525 申请日期 2001.10.26
申请人 MERCK &CO., INC.;BANYU PHARMACEUTICAL CO., LTD. 发明人 PETRILLO, DANIEL, E.;WIESSMAN, STEVEN, A.;ROSSEN, KAI;HIRAGA, SHOUICHI;SATAKE, NOBUYA
分类号 C07H19/23;A61K31/33;A61K31/55;A61K31/70;C07B61/00;C07H17/02;(IPC1-7):A61K31/33 主分类号 C07H19/23
代理机构 代理人
主权项
地址